The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Digital Companion Diagnostics Market Research Report 2025
Synopsis
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on.
The global Digital Companion Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Digital Companion Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Companion Diagnostics.
Report Scope
The Digital Companion Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Digital Companion Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Companion Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetic Laboratories, Inc.
Qiagen Manchester, Ltd.
Roche
Dako North America
Abbott
ICON plc
Illumina, Inc
Thermo Fisher
Segment by Type
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Segment by Application
Breast Cancer
Melanoma
Lung Cancer
Colorectal Cancer
Infectious Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Companion Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on.
The global Digital Companion Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Digital Companion Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Companion Diagnostics.
Report Scope
The Digital Companion Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Digital Companion Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Companion Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetic Laboratories, Inc.
Qiagen Manchester, Ltd.
Roche
Dako North America
Abbott
ICON plc
Illumina, Inc
Thermo Fisher
Segment by Type
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Segment by Application
Breast Cancer
Melanoma
Lung Cancer
Colorectal Cancer
Infectious Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Companion Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Digital Companion Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Melanoma
1.3.4 Lung Cancer
1.3.5 Colorectal Cancer
1.3.6 Infectious Disease
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Companion Diagnostics Market Perspective (2019-2030)
2.2 Digital Companion Diagnostics Growth Trends by Region
2.2.1 Global Digital Companion Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Digital Companion Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Digital Companion Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Digital Companion Diagnostics Market Dynamics
2.3.1 Digital Companion Diagnostics Industry Trends
2.3.2 Digital Companion Diagnostics Market Drivers
2.3.3 Digital Companion Diagnostics Market Challenges
2.3.4 Digital Companion Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Companion Diagnostics Players by Revenue
3.1.1 Global Top Digital Companion Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital Companion Diagnostics Revenue
3.4 Global Digital Companion Diagnostics Market Concentration Ratio
3.4.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2023
3.5 Digital Companion Diagnostics Key Players Head office and Area Served
3.6 Key Players Digital Companion Diagnostics Product Solution and Service
3.7 Date of Enter into Digital Companion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Companion Diagnostics Breakdown Data by Type
4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2025-2030)
5 Digital Companion Diagnostics Breakdown Data by Application
5.1 Global Digital Companion Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Digital Companion Diagnostics Market Size (2019-2030)
6.2 North America Digital Companion Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Digital Companion Diagnostics Market Size by Country (2019-2024)
6.4 North America Digital Companion Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Companion Diagnostics Market Size (2019-2030)
7.2 Europe Digital Companion Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Digital Companion Diagnostics Market Size by Country (2019-2024)
7.4 Europe Digital Companion Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Companion Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Digital Companion Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Companion Diagnostics Market Size (2019-2030)
9.2 Latin America Digital Companion Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Digital Companion Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Digital Companion Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Companion Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Digital Companion Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Myriad Genetic Laboratories, Inc.
11.1.1 Myriad Genetic Laboratories, Inc. Company Detail
11.1.2 Myriad Genetic Laboratories, Inc. Business Overview
11.1.3 Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Introduction
11.1.4 Myriad Genetic Laboratories, Inc. Revenue in Digital Companion Diagnostics Business (2019-2024)
11.1.5 Myriad Genetic Laboratories, Inc. Recent Development
11.2 Qiagen Manchester, Ltd.
11.2.1 Qiagen Manchester, Ltd. Company Detail
11.2.2 Qiagen Manchester, Ltd. Business Overview
11.2.3 Qiagen Manchester, Ltd. Digital Companion Diagnostics Introduction
11.2.4 Qiagen Manchester, Ltd. Revenue in Digital Companion Diagnostics Business (2019-2024)
11.2.5 Qiagen Manchester, Ltd. Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Digital Companion Diagnostics Introduction
11.3.4 Roche Revenue in Digital Companion Diagnostics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Dako North America
11.4.1 Dako North America Company Detail
11.4.2 Dako North America Business Overview
11.4.3 Dako North America Digital Companion Diagnostics Introduction
11.4.4 Dako North America Revenue in Digital Companion Diagnostics Business (2019-2024)
11.4.5 Dako North America Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Digital Companion Diagnostics Introduction
11.5.4 Abbott Revenue in Digital Companion Diagnostics Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 ICON plc
11.6.1 ICON plc Company Detail
11.6.2 ICON plc Business Overview
11.6.3 ICON plc Digital Companion Diagnostics Introduction
11.6.4 ICON plc Revenue in Digital Companion Diagnostics Business (2019-2024)
11.6.5 ICON plc Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Detail
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Digital Companion Diagnostics Introduction
11.7.4 Illumina, Inc Revenue in Digital Companion Diagnostics Business (2019-2024)
11.7.5 Illumina, Inc Recent Development
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Detail
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher Digital Companion Diagnostics Introduction
11.8.4 Thermo Fisher Revenue in Digital Companion Diagnostics Business (2019-2024)
11.8.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Immunohistochemistry (IHC)
Table 4. Key Players of In Situ Hybridization (ISH)
Table 5. Key Players of Next Generation Sequencing (NGS)
Table 6. Global Digital Companion Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Digital Companion Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Digital Companion Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Digital Companion Diagnostics Market Share by Region (2019-2024)
Table 10. Global Digital Companion Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Digital Companion Diagnostics Market Share by Region (2025-2030)
Table 12. Digital Companion Diagnostics Market Trends
Table 13. Digital Companion Diagnostics Market Drivers
Table 14. Digital Companion Diagnostics Market Challenges
Table 15. Digital Companion Diagnostics Market Restraints
Table 16. Global Digital Companion Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Digital Companion Diagnostics Market Share by Players (2019-2024)
Table 18. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2023)
Table 19. Ranking of Global Top Digital Companion Diagnostics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Digital Companion Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Digital Companion Diagnostics Product Solution and Service
Table 23. Date of Enter into Digital Companion Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Digital Companion Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Digital Companion Diagnostics Revenue Market Share by Type (2019-2024)
Table 27. Global Digital Companion Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Digital Companion Diagnostics Revenue Market Share by Type (2025-2030)
Table 29. Global Digital Companion Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Digital Companion Diagnostics Revenue Market Share by Application (2019-2024)
Table 31. Global Digital Companion Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Digital Companion Diagnostics Revenue Market Share by Application (2025-2030)
Table 33. North America Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Digital Companion Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Digital Companion Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Digital Companion Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Digital Companion Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Digital Companion Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Digital Companion Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Digital Companion Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Myriad Genetic Laboratories, Inc. Company Detail
Table 49. Myriad Genetic Laboratories, Inc. Business Overview
Table 50. Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Product
Table 51. Myriad Genetic Laboratories, Inc. Revenue in Digital Companion Diagnostics Business (2019-2024) & (US$ Million)
Table 52. Myriad Genetic Laboratories, Inc. Recent Development
Table 53. Qiagen Manchester, Ltd. Company Detail
Table 54. Qiagen Manchester, Ltd. Business Overview
Table 55. Qiagen Manchester, Ltd. Digital Companion Diagnostics Product
Table 56. Qiagen Manchester, Ltd. Revenue in Digital Companion Diagnostics Business (2019-2024) & (US$ Million)
Table 57. Qiagen Manchester, Ltd. Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Digital Companion Diagnostics Product
Table 61. Roche Revenue in Digital Companion Diagnostics Business (2019-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Dako North America Company Detail
Table 64. Dako North America Business Overview
Table 65. Dako North America Digital Companion Diagnostics Product
Table 66. Dako North America Revenue in Digital Companion Diagnostics Business (2019-2024) & (US$ Million)
Table 67. Dako North America Recent Development
Table 68. Abbott Company Detail
Table 69. Abbott Business Overview
Table 70. Abbott Digital Companion Diagnostics Product
Table 71. Abbott Revenue in Digital Companion Diagnostics Business (2019-2024) & (US$ Million)
Table 72. Abbott Recent Development
Table 73. ICON plc Company Detail
Table 74. ICON plc Business Overview
Table 75. ICON plc Digital Companion Diagnostics Product
Table 76. ICON plc Revenue in Digital Companion Diagnostics Business (2019-2024) & (US$ Million)
Table 77. ICON plc Recent Development
Table 78. Illumina, Inc Company Detail
Table 79. Illumina, Inc Business Overview
Table 80. Illumina, Inc Digital Companion Diagnostics Product
Table 81. Illumina, Inc Revenue in Digital Companion Diagnostics Business (2019-2024) & (US$ Million)
Table 82. Illumina, Inc Recent Development
Table 83. Thermo Fisher Company Detail
Table 84. Thermo Fisher Business Overview
Table 85. Thermo Fisher Digital Companion Diagnostics Product
Table 86. Thermo Fisher Revenue in Digital Companion Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Thermo Fisher Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Digital Companion Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Digital Companion Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. In Situ Hybridization (ISH) Features
Figure 6. Next Generation Sequencing (NGS) Features
Figure 7. Global Digital Companion Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Digital Companion Diagnostics Market Share by Application: 2023 VS 2030
Figure 9. Breast Cancer Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Colorectal Cancer Case Studies
Figure 13. Infectious Disease Case Studies
Figure 14. Others Case Studies
Figure 15. Digital Companion Diagnostics Report Years Considered
Figure 16. Global Digital Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Digital Companion Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Digital Companion Diagnostics Market Share by Region: 2023 VS 2030
Figure 19. Global Digital Companion Diagnostics Market Share by Players in 2023
Figure 20. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2023
Figure 22. North America Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Digital Companion Diagnostics Market Share by Country (2019-2030)
Figure 24. United States Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Digital Companion Diagnostics Market Share by Country (2019-2030)
Figure 28. Germany Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Digital Companion Diagnostics Market Share by Region (2019-2030)
Figure 36. China Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Digital Companion Diagnostics Market Share by Country (2019-2030)
Figure 44. Mexico Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Digital Companion Diagnostics Market Share by Country (2019-2030)
Figure 48. Turkey Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Digital Companion Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Myriad Genetic Laboratories, Inc. Revenue Growth Rate in Digital Companion Diagnostics Business (2019-2024)
Figure 51. Qiagen Manchester, Ltd. Revenue Growth Rate in Digital Companion Diagnostics Business (2019-2024)
Figure 52. Roche Revenue Growth Rate in Digital Companion Diagnostics Business (2019-2024)
Figure 53. Dako North America Revenue Growth Rate in Digital Companion Diagnostics Business (2019-2024)
Figure 54. Abbott Revenue Growth Rate in Digital Companion Diagnostics Business (2019-2024)
Figure 55. ICON plc Revenue Growth Rate in Digital Companion Diagnostics Business (2019-2024)
Figure 56. Illumina, Inc Revenue Growth Rate in Digital Companion Diagnostics Business (2019-2024)
Figure 57. Thermo Fisher Revenue Growth Rate in Digital Companion Diagnostics Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
